SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,909.68 -325.78
( -0.42%)

Global Indices

Nasdaq

53,360.44 -120.34
(-0.23%)

Dow Jones

7,713.14 -52.92
(-0.68%)

Hang Seng

65,335.94 -2,124.79
(-3.15%)

Nikkei 225

10,747.45 19.41
(0.18%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

94348

INE1BZN01016

58.5748291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CURIS

12.86

89.09

EPS(TTM)

Face Value()

Div & Yield %

8.57

Back

accedere ltd

Accedere reports consolidated net profit of Rs 0.05 crore in the June 2026 quarter

Aug 14,2026

Net profit of Accedere remain constant at Rs 0.05 crore in the quarter ended June 2026 and also during the previous quarter ended June 2025. Sales rose 32.89% to Rs 1.01 crore in the quarter ended June 2026 as against Rs 0.76 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.01	0.76	33
OPM %	13.86	13.16	-
PBDT	0.14	0.10	40
PBT	0.09	0.07	29
NP	0.05	0.05	0

76,909.68 -325.78 ( -0.42%)

53,360.44 -120.34 (-0.23%)

7,713.14 -52.92 (-0.68%)

65,335.94 -2,124.79 (-3.15%)

10,747.45 19.41 (0.18%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)